Regulatory Open Forum

 View Only
  • 1.  China NMPA: Thirty Guidelines Issued in July

    Posted 08-Sep-2023 17:01

    China NMPA issued 30 guidelines in July 2023, to guide manufacturers for local type testing, pre-clinical, clinical studies, and regulatory submissions. Some of the key areas covered in the review points and guidelines are included in the following:

    1.       Key review points for ultrasound imaging artificial intelligence software (process optimization) 

    2.       Key review points for performance evaluation on artificial intelligence analysis software for pathological images

    3.       Key review points for clinical evaluation on artificial intelligence analysis software for pathological images

    4.       Key review points for performance evaluation on artificial intelligence analysis software for blood disease flow cytometry

    5.       Key Review Points for Animal testing of extracorporeal membrane oxygenation (ECMO) consumable products

    6.       Guideline on continuous glucose monitoring system

    7.       Guideline on blood thawing device

    8.       Guideline on respiratory humidifier

    9.       Guideline on intestinal hydrotherapy machine

    10.   Guideline on molecular sieve oxygen generator

    11.   Guideline on bladder ultrasound scanner

    12.   Guideline on single-use peritoneal dialysis catheters

    13.   Guideline on respiratory filters

    14.   Guideline on oropharyngeal/nasopharyngeal airway

    15.   Guideline on liquid dressings

    16.   Guideline on gel dressings

    17.   Guideline on β-hydroxybutyric acid detection reagent

    18.   Guideline on methotrexate detection reagent

    19.   Guideline on anti-cyclic citrullinated peptide antibody detection reagent

    20.   Guideline on Gram-positive bacteria identification reagent

    21.   Guideline on transcatheter aortic valve system

    22.   Guideline on vascular intervention devices with lubricating coatings

    23.   Guideline on non-vascular self-expanding metal stent system

    24.   Guideline on medical device product benefits – risk determination

    25.   Guideline on extracorporeal membrane oxygenation (ECMO) temperature control equipment (draft)

    26.   Guideline on mobile ECG atrial fibrillation testing products

    27.   Guideline on insulin pumps

    28.   Guideline on high-flow respiratory therapy equipment

    29.   Clinical evaluation guideline on predicate comparison of ventilators

    30.   Clinical evaluation guideline on predicate comparison of hip prostheses

    Out of 30 review points and guidelines, only "Guideline on extracorporeal membrane oxygenation (ECMO) temperature control equipment" is the draft version, and the rest are the final one.

    Areas to pay attention to:

    If your product changes before the renewal, the manufacturer needs to apply modification on permission items to NMPA first. 

    In general, the parallel guidelines will be released right after the standards. If it is the first registration of your product, the manufacturer needs to comply with the latest guidelines.  

    If your product is undergoing changes, upgrades, or renewal and is related to the latest guideline mentioned above, please assess whether an upgrade testing is required to comply with the latest requirements of NMPA.

    If your products are impacted by the guidelines update or have any questions, please email me. 



    ------------------------------
    Grace Fu
    China Med Device, LLC
    MA, U.S.
    gpalma@ChinaMedDevice.com
    978-390-4453
    www.ChinaMedDevice.com
    ------------------------------


  • 2.  RE: China NMPA: Thirty Guidelines Issued in July

    Posted 04-Mar-2024 12:15

    Hi Grace,

    I see you are very up to date on NMPA guidelines. I'm am searching for drug/biologics related NMPA guidances/guidelines in English. Can you point me to a good source that avoids having to do a bunch of google translating?

    Thanks,
    Anna



    ------------------------------
    Anna Sedello, PhD, RAC-Drugs
    Executive Director of Regulatory Affairs
    Alpine Immune Sciences
    Redwood City CA
    United States
    ------------------------------